PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The TKI Lung Cancer Market in China

Improving Management of Gene and Cell Therapies

Building Healthcare's "Ground Truth" with AI

Advertisement
Personalized Medicine
Specialty Focus: Tackling Rare Mutation in CF
How one nonprofit and its out-front leader are joining forces with industry to advance a new personalized medicine approach for cystic fibrosis patients with nonsense mutations.
... /Read more/
Advertisement
Podcast Series: Clinical Data Management in Today's Rapidly Evolving World
Experts talk about science and innovation in clinical research and development
Learn More
Executive Profile
Paul Perreault: The Global CEO
Pharm Exec talks with CSL's top executive about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.
... /Read more/
Calendar
 
/ 4th Bio/Pharmaceutical Product Launch Summit 9/25-9/26 /
 
/ American Pharma Outsourcing Summit 10/2-10/3 /
 
/ Rare Diseases & Orphan Products Breakthrough Summit 10/15-10/16 /
 
/ 28th Annual Sharing Conference: Compliance 10/15-10/17 /
 
/ Basket & Umbrella Trials for Oncology 10/17-10/18 /
 
/ Women of Color in Pharma Second Annual Conference 11/2-11/3 /
 
/ Crossroads: An Artia Solutions Conference 11/7-11/9 /
 
Advertisement
Specialty Pharma
The Pharm Exec Podcast: Episode 16
Pharm Exec's Editor-in-Chief Lisa Henderson and European Editor Julian Upton join Christen Harm and Michelle Maskaly to talk about the topic of specialty pharma, which was featured in the magazine's September issue. They discuss the marketing, logistics, pricing, and other challenges executives in the specialty pharma industry face, as well as dive into the forces that are driving this segment of the industry and what the future will look like.
... /Read more/
Advertisement
A panel discussion with insights from emerging biopharma executives
Wednesday, October 3, 2018 at 11am EDT
Register now
Biosimilars
Biosimilars Battles Heat Up
With the rise in industry programs for developing biosimilars, tensions are high as innovator firms back strategies that appear designed to delay competition. Jill Wechsler reports.
... /Read more/
Advertisement
Leverage Your Data to Meet Rising Expectations within Life Sciences
On Demand
Read more
Supply Chain
Specialty Supply Chain Decisions
In today's drug development environment, there is no doubt that supply chain decisions are paramount in a product launch strategy, writes Lisa Henderson.
... /Read more/
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com